lots of activity already it would seem:
- Novartis close to acquiring Cytokinetics after biotech's PhIII heart disease win — WSJ
- Novartis to acquire Calypso Biotech for autoimmune treatment
- J&J makes $2B push into ADCs with Ambrx buyout in oncology deal spree: #JPM24
- Veracyte to buy C2i Genomics for up to $95M, includes $70M upfront
- Alphabet's Isomorphic inks first pharma deals with Eli Lilly and Novartis for $83M upfront, $2.9B in milestones
- Merck brings Harpoon Therapeutics and its PhI/II T cell engager into the fold for $680M: #JPM24
- Novartis strikes $250M buyout for Merck Serono spinout's autoimmune 'pipeline-in-a-drug': #JPM24
- Novartis licenses two cardiovascular RNAi drugs from Chinese biotech for $185M upfront: #JPM24
#JPM24 on X (Twitter)
GLTAH!
Ann: Imugene to Present at Annual JPMorgan Healthcare Conference, page-33
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.001(1.75%) |
Mkt cap ! $411.5M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.5¢ | $390.3K | 7.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 124999 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1243276 | 11 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |